HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Commerce Cmte. FDA reform mark-up delayed by negotiations with Administration.

This article was originally published in The Rose Sheet

Executive Summary

HOUSE FDA REFORM MARKUP DELAYED TO ALLOW NEGOTIATIONS WITH ADMINISTRATION in a final effort to forge consensus legislation. House Commerce Committee Chairman Rep. Thomas Bliley (R-Va.) already has met with HHS Secretary Shalala, and congressional and HHS staff began discussion of the Administration's concerns July 17. Mark-up of the legislation, which had been scheduled to begin during the week of July 15, has been delayed for two weeks until the last week of July, the Commerce Committee indicated.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel